Sanofi, GSK aim for COVID-19 vaccine price under $12

Sanofi, GSK aim for COVID-19 vaccine price under $12

Sanofi, which has partnered with GlaxoSmithKline to develop a COVID-19 vaccine, said the cost of the shot should be lower than $11.80, although production costs are still uncertain and final pricing will be based on dosing. Sanofi is developing another COVID-19 vaccine candidate with Translate Bio that uses messenger RNA technology.

Full Story: Reuters (9/5)